ASCO Reveals That Big Pharma Is Alive

This weekend, the annual American Society of Clinical Oncology (ASCO) kicked off in Chicago. The theme this year? Immunotherapy. The conference is traditionally littered with news from biotech companies revealing results from clinical studies, but this year’s event also included some news from big phama companies that haven’t been bursting with pipeline breakthroughs in years. Let’s take a look at some of the news out of the event. Firms Highlighted: Bristol-Myers Squibb, Merck, GlaxoSmithKline, Amgen, Galena Biopharma, BioMarin, Celgene. Bristol-Myers Squibb Source: BMY ASOC 2013 Presentation Bristol-Myers Squibb (click ticker for report: ) isn’t exactly what we’d call an under-appreciated company. Over the past year, shares are up 43%. However, this year’s ASCO only further ignited the fire. The company … Read more

Revisiting the Real Risks of Linn Energy

In recent months, energy producer Linn Energy (click ticker for report: ) has come under fire from the likes of Barron’s and hedge fund managers. The biggest issue for Linn bears, prior to the merger agreement with Berry Petroleum (BRY) was that the company issued unrealistic measures for distributable cash flow per share and for adjusted EBITDA. Both metrics are non-GAAP figures, which can sometimes raise a red flag—especially when a firm’s management team comes under pressure. Let’s take a look at Linn’s metrics and the issues swirling around the stock. Linn’s Metrics After the attacks on its metrics, Linn went on the offensive, providing a supplemental presentation elaborating on the company’s non-GAAP metrics. Source: Linn “Short Seller Response” The … Read more

What Did We Learn About Apple from the All Things D Conference?

During the past few weeks, Apple (click ticker for report: ) has re-entered the market’s collective psyche in a big way. First, CEO Tim Cook was grilled by congress over how the company skirts US income taxes. While Apple broke no laws, the company still got targeted for its complex tax avoidance structure. We think this news couldn’t be any less material, especially since literally thousands of other companies use similar tactics. In our view, Apple was singled out because it’s one of the largest companies in the world. The hearing is nothing more than a silly sideshow, and we doubt it will amount to anything more than a few weeks of headlines. On the other hand, Cook spoke on … Read more

Market Swoons in Late Trading Friday

All data in this article is as of the published date, May 31, 2013. Reiterating Our View As we had outlined in our May 23 piece, “The Market Doesn’t Go Straight Up,” we identified a number of reasons why the risk-reward ratio had tilted against the investor: increased market volatility, the significant imbalance in the Valuentum Buying Index rankings (click here), and unfavorable relative/comparable market value comparisons versus historical trends. As such, we opened a put option on the broader market ETF, the SPDR S&P 500 Trust (SPY), in our Best Ideas portfolio for added downward protection ($160 strike, Dec 2013 expiration) well in advance of the sell-off Friday (we already have roughly a 30%+ cash position in our Best … Read more

Dividend Increases for the Week Ending May 31

Below we provide a list of firms that upped their dividends for the week ending May 31. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports, please click here. Firms Raising Their Dividends This Week American Eagle Outfitters (AEO): now $0.125 per share quarterly dividend, was $0.11. Canadian Imperial Bank of Commerce (CM): now C$0.96 per share quarterly dividend, was $0.94. CryoLife (CRY): now $0.0275 per share quarterly dividend, was $0.025. Daktronics (DAKT): now $0.12 per share semi-annual dividend, was $0.115. Eastern Insurance Holdings (EIHI): now $0.11 per share quarterly dividend, was $0.09. Hill-Rom Holdings (HRC): now $0.1375 per share quarterly dividend, was $0.125. Lowe’s Companies (LOW): now … Read more